The cellular heterogeneity of breast cancers still represents a major therapeutic challenge.
The latest genomic studies have classified breast cancers in distinct clusters to inform the …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Purpose Breast cancer is a major public health concern worldwide and shows significant
heterogeneity between male and female. Knowing the global incidence landscape in both …

Background Due to its rarity, few studies have characterized the epidemiology of male
breast cancer. The purpose of this study was to determine survival and risk factors for male …

The big data revolution presents an exciting frontier to expand public health research,
broadening the scope of research and increasing the precision of answers. Despite these …

Male breast cancer (MBC) is a rare but aggressive malignancy with cellular and
immunological characteristics that remain unclear. Here, we perform transcriptomic analysis …

Drug resistance is one of the most critical challenges facing researchers in treating breast
cancer. Despite numerous treatments for breast cancer, including conventional chemical …

Background Cancer survival estimates provide insights into the effectiveness of early
detection and treatment. The stage of cancer at diagnosis is an important determinant of …

Simple Summary No studies have discussed machine learning algorithms to predict
recurrence within 10 years after breast cancer surgery. Artificial neural networks (ANN) …

PURPOSE Selection of appropriate adjuvant therapy to ultimately reduce the risk of breast
cancer (BC) recurrence is a challenge for medical oncologists. Several automated risk …